Leaders need to understand the growing range of AI applications—and how to capitalize on their potential while avoiding the risks.
![josh-kellar-tcm9-241777.jpg](https://web-assets.bcg.com/dims4/default/d86b2be/2147483647/strip/true/crop/298x298+0+0/resize/500x500!/format/webp/quality/90/?url=http%3A%2F%2Fboston-consulting-group-brightspot.s3.amazonaws.com%2F58%2F2d%2F4663e76487e058a4fb693df5b0ba%2Fjosh-kellar-tcm9-241777.jpg)
Education
- PhD, materials science and engineering, Northwestern University
- MA, creative writing, Boston University
- BS, physics and English, Georgetown University
Joshua Kellar leads Boston Consulting Group's Global Scientist Network of over 500 MDs and PhDs and co-leads BCG's medical response to COVID-19 (including diagnostics, therapies, vaccines, and health system response). Josh focuses on innovation in health care that drives public good. His particular areas of focus are: digital, scientific, and payment-model based innovation. He works closely with integrated health systems, private investors, and biopharmaceutical and medical technology companies.
Before joining the firm, Josh was a postdoctoral fellow in oncology at Northwestern University.